EVO

#2631
Evotec SE - American Depositary Shares each representing 1/2 of
2.1 8 USD
-0.10%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.16
2.20
Year Range
2.16
4.27
Daily Change
-10.29%
Monthly Change
-22.70%
6 month change
-40.11%
Year Change
-48.95%
Previous Close
2.4 3
Open
2.1 7
Low
2.1 6
High
2.2 0
Volume
96
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2597
AMPH
Amphastar Pharmaceuticals, Inc. - Common Stock
18.79 USD-2.59%-6.19%-6.56%-22.93%828.51 M USD
2611
ESPR
Esperion Therapeutics, Inc. - Common Stock
3.18 USD0.00%+0.63%+0.63%+169.49%818.63 M USD
2740
IRWD
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
4.03 USD-4.28%-12.96%+6.90%+444.59%663.39 M USD
2912
AQST
Aquestive Therapeutics, Inc. - Common Stock
4.06 USD0.00%-6.02%-3.56%+0.50%509.33 M USD

Frequently asked questions about Evotec SE - American Depositary Shares each representing 1/2 of

What is the Evotec SE - American Depositary Shares each representing 1/2 of stock price today?

The current price of Evotec SE - American Depositary Shares each representing 1/2 of (EVO) is 2.18. Over the past 24 hours, the stock has changed by -10.29%. Follow the EVO chart for real-time price dynamics.

What is the stock ticker of Evotec SE - American Depositary Shares each representing 1/2 of?

Evotec SE - American Depositary Shares each representing 1/2 of trades under the ticker EVO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Evotec SE - American Depositary Shares each representing 1/2 of stock going up?

EVO has changed by -23.24% over the last week, -22.70% over the last month, and -48.95% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Evotec SE - American Depositary Shares each representing 1/2 of release financial reports?

Yes. You can track Evotec SE - American Depositary Shares each representing 1/2 of financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

How many employees does Evotec SE - American Depositary Shares each representing 1/2 of have?

As of the latest available data, Evotec SE - American Depositary Shares each representing 1/2 of has 4 553 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Evotec SE - American Depositary Shares each representing 1/2 of stock?

You can buy Evotec SE - American Depositary Shares each representing 1/2 of (EVO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Evotec SE - American Depositary Shares each representing 1/2 of stock?

Investing in Evotec SE - American Depositary Shares each representing 1/2 of requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EVO chart and related analysis on metatrader.com as part of your research.

Evotec SE - American Depositary Shares each representing 1/2 of

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology.

News